Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders' Equity (Deficit)

v3.25.4
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
Total
O 2024 A1 Dividends [Member]
O 2025 A1 Dividends [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Treasury Stock [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
O 2024 A1 Dividends [Member]
Accumulated Deficit [Member]
O 2025 A1 Dividends [Member]
Beginning balance at Nov. 30, 2023 $ (11,031,232)     $ 148,492 $ 43,411,143 $ (23,431,685) $ (31,159,182)    
Beginning balance, shares at Nov. 30, 2023       14,849,246          
Exercise of stock options 76,402     $ 204 76,198        
Exercise of stock options, shares       20,373          
Compensatory element of stock options 781,128       781,128        
Treasury stock (1,423,871)         (1,423,871)      
Dividends declared ($0.25 per share)   $ (2,020,539)           $ (2,020,539)  
Net Income (Loss) 402,095           402,095    
Ending balance at Nov. 30, 2024 (13,216,017)     $ 148,696 44,268,469 (24,855,556) (32,777,626)    
Ending balance, shares at Nov. 30, 2024       14,869,619          
Exercise of stock options 23,101     $ 75 23,026        
Exercise of stock options, shares       7,500          
Compensatory element of stock options 417,101       417,101        
Treasury stock (169,502)         (169,502)      
Dividends declared ($0.25 per share)     $ (3,231,227)           $ (3,231,227)
Net Income (Loss) (2,429,385)           (2,429,385)    
Ending balance at Nov. 30, 2025 $ (18,605,929)     $ 148,771 $ 44,708,596 $ (25,025,058) $ (38,438,238)    
Ending balance, shares at Nov. 30, 2025       14,877,119